Clinical Science | Novartis

Media Release
Jun 11, 2021
Novartis investigational oral therapy iptacopan (LNP023) shows benefit as monotherapy in treatment-naïve patients with rare and life-threatening blood disorder paroxysmal nocturnal hemoglobinuria
Story
Apr 20, 2020
Going the extra mile to keep clinical trials on track during the COVID-19 pandemic
Story
Sep 08, 2015
Putting patients first
Story
Apr 14, 2017
Women in Science: Medy Attalla
Story
Oct 13, 2016
Women in Science: Tania Small
Story
Feb 17, 2015
Researchers aim to beat trick play by tumors with drug combo
Story
Feb 10, 2016
Leveraging the liver’s ability to heal scarred tissue